TechInsights partners with Cipher to harness machine learning
The partnership will see ML used to leverage patent intelligence to reveal insight about the future direction of the semiconductor industry.
Read more23rd April 2021
Diagnostics and Drug Development: Is Artificial Intelligence conquering other sectors?
The Artificial Intelligence (AI) wave is sweeping the world and taking over one industry at a time. It is everywhere around us – from suggesting what to view or buy, categorising our photos/emails, even figuring out the fastest route to reach our destination. With the many applications of AI, you can see an increase of applications within the healthcare sector. This can range from accessing medical care virtually to the production of new drug treatments which can then be made more readily available for us.
This report looks at the organisations and technologies dominating this patent landscape and have spotted some interesting trends. We have looked at three key technology areas representing AI in Diagnostics and Drug Development:
- Drug Development
- Medical Imaging
- Diagnostic and Treatment
But who owns these technologies and is dominating this innovative space?
Source: Cipher
Fill out the form below to gain access to our report on Diagnostics and Drug Development: Is Artificial Intelligence conquering other sectors? and discover the latest trends emerging in this patent landscape and how the major tech companies are dominating this space.
Download Diagnostics and Drug Development report
Diagnostics and Drug Development
Key takeaways of the report include:
Tech Giants are the major innovators in AI for Diagnostics and Drug Development, rather than Pharma
Medical Imaging is the largest area in AI for Diagnostics and Drug Development
China is leading the way in development of innovation in this space
Diagnostics and Drug Development
Insights & Events
Europe and Asia edging ahead for green hydrogen technology supremacy
The green hydrogen sector will see rapid technological innovation as the sector continues to scale and evolve. This is the lead finding of a joint report by Cipher and Fitch Solutions.
Read more
BlackBerry Patent Sale Announced
Using the Cipher Universal Technology Taxonomy we have identified the top areas of technology innovation protected by the BlackBerry portfolio.
Read more
IAM Strategy 300 2022
Nigel Swycher, CEO of Cipher and Steve Harris, CTO, are both named in the IAM Strategy 300 Global Leaders list for 2022.
Read more
Universal Technology Taxonomy – Insight
Introducing the world’s first Universal Technology Taxonomy. This article sheds light on why Cipher launched the world’s first universal technology to classify patents and example analysis using UTT.
Read more
Oil and Gas Supermajors – Energy Transition
We put a lens on the invention and innovation being made in critical technologies powering the energy transition. This analysis has been done using Cipher’s Universal Technology Taxonomy.
Read moreWith Cipher you can…
Optimise your portfolio
Ensure you have the right portfolio to meet your strategic patenting objectives.
Gather competitor intelligence
Understand who’s doing what by automating patent to technology mapping.
Model cross licensing
Combine patent and revenue data to determine rational licensing outcomes.
Manage your budget
Justify patent budgets and communicate the impact of your investment.
Conduct due diligence
Automate manual reviews for efficient execution of M&A and licensing transactions.
Tackle inbound patent assertion
Be prepared with evidence to create a fast and effective threat assessment.
Benchmark your portfolio
Assess your portfolio in comparison to other owners through your technology lens.
Monetise your portfolio
Identify opportunities to create value through licensing or sale of patent assets.
Predict technology trends
Track new technologies and discover the unknown owners of future innovation.
Create Risk Mitigation Strategies
Understand the materiality of your threats to define your risk mitigation strategy.